FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
Reply |
|
Thread Tools | Display Modes |
02-17-2009, 11:52 AM | #1 | |||
|
||||
Magnate
|
Depomed Initiates Phase I Trial for DM-1992 Program in Parkinson’s Disease Following Positive Results of Preclinical Studies Sponsored by The Michael J. Fox Foundation
CentralDaily.com / Tuesday, Feb. 17, 2009 MENLO PARK, Calif. — Depomed, Inc. (NASDAQ / DEPO) today announced that it has dosed the first patient in a Phase I trial for its DM-1992 program in Parkinson’s disease based on positive results from preclinical studies sponsored by The Michael J. Fox Foundation for Parkinson’s Research. DM-1992 is an investigative novel gastric retentive extended-release dosage form of Levodopa/Carbidopa, a marketed therapy used in the treatment of Parkinson’s disease. Click above to find the source
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller |
|||
Reply With Quote |
"Thanks for this!" says: | bandido1 (02-17-2009) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Melanoma & PD...Phase I begins for DM-1992 | Parkinson's Disease | |||
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lat | ALS News & Research | |||
Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development | ALS News & Research |